Coronary products of Sino Medical Sciences Technology Inc. (688108.SH) have obtained registration certificates overseas.

Sino Medical Sciences Technology Inc. (688108.SH) announced that in September 2024, the company submitted the registration application materials for its HT Supreme drug-eluting stent system to the National Administration of Drugs, Food and Medical Technology of the Argentine Republic (ANMAT). In October 2024, the company also submitted registration application materials for its HT Supreme drug-eluting stent system, Tytrak PTCA balloon dilatation catheter, and NC Thonic non-compliant PTCA balloon dilatation catheter to the National Health Regulatory, Control and Surveillance Agency of the Republic of Ecuador (ARCSA). The company recently received notifications from ANMAT and ARCSA, stating that the registration application materials have been approved by both agencies. The registration of the company's products in the Argentine Republic and the Republic of Ecuador is an important part of the company's overseas business expansion and will play a significant role in promoting and facilitating the sales of the company's products overseas.